Skip to content

Investigation of laparoscopic hepatectomy (lobectomy or more)

Investigation of laparoscopic hepatectomy (lobectomy or more) - Investigation of laparoscopic hepatectomy (lobectomy or more)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020972
Enrollment
100
Registered
2016-02-10
Start date
2016-02-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic hepatectomy

Interventions

Laparoscopic hepatectomy (lobectomy or more)

Sponsors

Osaka Medical Center for Cancer and Cardiovascular Diseases
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PS 0-1 Major organ function (bone marrow, heart, liver, kidney, lung, etc) are maintained. Written informed consent

Exclusion criteria

Exclusion criteria: R2 resection, estimated remnant liver volume > 30%

Design outcomes

Primary

MeasureTime frame
Perioperative factors (operative time, estimated blood loss, conversion rate to open suregry, transfusion rate, etc), adverse effects, postoperative hospital stay.

Secondary

MeasureTime frame
RFS, OS

Countries

Japan

Contacts

Public ContactShogo Kobayashi

Osaka Medical Center for Cancer and Cardiovascular Diseases Surgery

s-kobayashi@umin.ac.jp+81-6-6872-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026